QQQ   329.60 (-0.81%)
AAPL   174.28 (+0.72%)
MSFT   292.15 (-0.19%)
META   176.73 (-1.53%)
GOOGL   121.06 (-0.53%)
AMZN   142.27 (-1.73%)
TSLA   912.71 (-0.76%)
NVDA   184.78 (-2.12%)
NIO   20.63 (-1.34%)
BABA   91.36 (-1.39%)
AMD   97.96 (-2.24%)
MU   61.91 (-3.05%)
T   18.38 (-1.02%)
CGC   3.87 (+2.38%)
F   16.20 (-1.40%)
GE   79.91 (-1.43%)
DIS   124.28 (-0.54%)
AMC   24.46 (-1.41%)
PYPL   100.14 (-1.90%)
PFE   49.53 (-0.66%)
NFLX   241.94 (-1.53%)
QQQ   329.60 (-0.81%)
AAPL   174.28 (+0.72%)
MSFT   292.15 (-0.19%)
META   176.73 (-1.53%)
GOOGL   121.06 (-0.53%)
AMZN   142.27 (-1.73%)
TSLA   912.71 (-0.76%)
NVDA   184.78 (-2.12%)
NIO   20.63 (-1.34%)
BABA   91.36 (-1.39%)
AMD   97.96 (-2.24%)
MU   61.91 (-3.05%)
T   18.38 (-1.02%)
CGC   3.87 (+2.38%)
F   16.20 (-1.40%)
GE   79.91 (-1.43%)
DIS   124.28 (-0.54%)
AMC   24.46 (-1.41%)
PYPL   100.14 (-1.90%)
PFE   49.53 (-0.66%)
NFLX   241.94 (-1.53%)
QQQ   329.60 (-0.81%)
AAPL   174.28 (+0.72%)
MSFT   292.15 (-0.19%)
META   176.73 (-1.53%)
GOOGL   121.06 (-0.53%)
AMZN   142.27 (-1.73%)
TSLA   912.71 (-0.76%)
NVDA   184.78 (-2.12%)
NIO   20.63 (-1.34%)
BABA   91.36 (-1.39%)
AMD   97.96 (-2.24%)
MU   61.91 (-3.05%)
T   18.38 (-1.02%)
CGC   3.87 (+2.38%)
F   16.20 (-1.40%)
GE   79.91 (-1.43%)
DIS   124.28 (-0.54%)
AMC   24.46 (-1.41%)
PYPL   100.14 (-1.90%)
PFE   49.53 (-0.66%)
NFLX   241.94 (-1.53%)
QQQ   329.60 (-0.81%)
AAPL   174.28 (+0.72%)
MSFT   292.15 (-0.19%)
META   176.73 (-1.53%)
GOOGL   121.06 (-0.53%)
AMZN   142.27 (-1.73%)
TSLA   912.71 (-0.76%)
NVDA   184.78 (-2.12%)
NIO   20.63 (-1.34%)
BABA   91.36 (-1.39%)
AMD   97.96 (-2.24%)
MU   61.91 (-3.05%)
T   18.38 (-1.02%)
CGC   3.87 (+2.38%)
F   16.20 (-1.40%)
GE   79.91 (-1.43%)
DIS   124.28 (-0.54%)
AMC   24.46 (-1.41%)
PYPL   100.14 (-1.90%)
PFE   49.53 (-0.66%)
NFLX   241.94 (-1.53%)
NYSE:CLB

Core Laboratories - CLB Stock Forecast, Price & News

$15.99
-0.16 (-0.99%)
(As of 08/17/2022 09:52 AM ET)
Add
Compare
Today's Range
$15.94
$16.15
50-Day Range
$15.40
$30.27
52-Week Range
$15.21
$35.83
Volume
627 shs
Average Volume
463,386 shs
Market Capitalization
$740.82 million
P/E Ratio
84.16
Dividend Yield
0.24%
Price Target
$23.33

Core Laboratories MarketRank™ Forecast

Analyst Rating
Reduce
1.33 Rating Score
Upside/​Downside
45.9% Upside
$23.33 Price Target
Short Interest
Bearish
9.99% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.95mentions of Core Laboratories in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
75.93%
From $0.54 to $0.95 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.62 out of 5 stars

Oils/Energy Sector

60th out of 257 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

6th out of 23 stocks

CLB stock logo

About Core Laboratories (NYSE:CLB) Stock

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research note on Wednesday, May 11th. Stifel Nicolaus dropped their target price on Core Laboratories from $26.00 to $20.00 in a research report on Tuesday, July 26th. Finally, Morgan Stanley dropped their target price on Core Laboratories from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, August 1st.

Core Laboratories Trading Down 2.7 %

CLB Stock opened at $16.15 on Wednesday. The company has a current ratio of 2.08, a quick ratio of 1.53 and a debt-to-equity ratio of 1.08. Core Laboratories has a 12-month low of $15.21 and a 12-month high of $35.83. The stock has a market cap of $748.15 million, a price-to-earnings ratio of 85.00, a PEG ratio of 0.78 and a beta of 2.60. The business's 50-day moving average is $19.00 and its 200 day moving average is $25.17.

Core Laboratories (NYSE:CLB - Get Rating) last posted its quarterly earnings data on Wednesday, July 27th. The oil and gas company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). Core Laboratories had a return on equity of 16.12% and a net margin of 1.82%. The firm had revenue of $120.90 million during the quarter, compared to analyst estimates of $121.35 million. During the same quarter in the previous year, the firm posted $0.18 earnings per share. The company's quarterly revenue was up 1.8% on a year-over-year basis. On average, sell-side analysts anticipate that Core Laboratories will post 0.54 EPS for the current fiscal year.

Core Laboratories Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 29th. Investors of record on Monday, August 8th will be issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.25%. The ex-dividend date is Friday, August 5th. Core Laboratories's payout ratio is 21.05%.

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

Core Laboratories: A Speculative Buy At Present Levels
SLB or CLB: Which Is the Better Value Stock Right Now?
Core Laboratories goes ex-dividend tomorrow
Why Energy Stocks Dropped on Monday
Core Laboratories (CLB) Q2 Earnings Match Estimates
Core Laboratories (NYSE:CLB) Shares Gap Down to $17.66
Why Shares in Core Labs Fell Today
Why Core Labs Stock Dived by More Than 10% Today
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Company Calendar

Ex-Dividend for 5/31 Dividend
5/06/2022
Dividend Payable
5/31/2022
Last Earnings
7/27/2022
Ex-Dividend for 8/29 Dividend
8/05/2022
Today
8/17/2022
Dividend Payable
8/29/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,700
Year Founded
1936

Price Target and Rating

Average Stock Price Forecast
$23.33
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+45.9%
Consensus Rating
Reduce
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

Net Income
$19.73 million
Pretax Margin
4.48%

Debt

Sales & Book Value

Annual Sales
$470.25 million
Cash Flow
$1.08 per share
Book Value
$3.75 per share

Miscellaneous

Free Float
46,130,000
Market Cap
$740.82 million
Optionable
Optionable
Beta
2.59

Social Links


Key Executives

  • Mr. Lawrence V. Bruno (Age 62)
    Chairman, CEO, Pres & COO
    Comp: $1.61M
  • Mr. Christopher Scott Hill (Age 52)
    Sr. VP & CFO
    Comp: $702.65k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 54)
    Sr. VP of Corp. Devel. & Investor Relations
    Comp: $612.71k
  • Mr. Mark Damian Tattoli (Age 50)
    Sr. VP, Sec. & Gen. Counsel
    Comp: $948.9k
  • Mr. Kevin G. Daniels (Age 58)
    Chief Accounting Officer, Treasurer & VP
  • Mr. Jacobus Schouten (Age 67)
    Managing Director
  • J. Donald Dumas Jr.
    Sr. VP of Production Enhancement & Bus. Devel.













CLB Stock - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "sell" CLB shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2022?

3 equities research analysts have issued 1-year target prices for Core Laboratories' stock. Their CLB share price forecasts range from $20.00 to $32.00. On average, they expect the company's share price to reach $23.33 in the next year. This suggests a possible upside of 44.4% from the stock's current price.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2022?

Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB stock has decreased by 27.6% and is now trading at $16.15.
View the best growth stocks for 2022 here
.

Are investors shorting Core Laboratories?

Core Laboratories saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 4,590,000 shares, a decline of 11.2% from the July 15th total of 5,170,000 shares. Based on an average daily volume of 459,400 shares, the days-to-cover ratio is currently 10.0 days. Currently, 10.0% of the shares of the company are short sold.
View Core Laboratories' Short Interest
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our CLB earnings forecast
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) issued its earnings results on Wednesday, July, 27th. The oil and gas company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.14 by $0.02. The oil and gas company had revenue of $120.90 million for the quarter, compared to analyst estimates of $121.35 million. Core Laboratories had a net margin of 1.82% and a trailing twelve-month return on equity of 16.12%. The firm's revenue was up 1.8% on a year-over-year basis. During the same period last year, the business earned $0.18 earnings per share.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 29th. Stockholders of record on Monday, August 8th will be paid a dividend of $0.01 per share on Monday, August 29th. This represents a $0.04 dividend on an annualized basis and a yield of 0.25%. The ex-dividend date is Friday, August 5th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.24%. The dividend payout ratio is 21.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 4.21% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $0.13-$0.18 for the period, compared to the consensus estimate of $0.20. The company issued revenue guidance of $123.00 million-$129.00 million, compared to the consensus revenue estimate of $125.12 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (4.30%), Van ECK Associates Corp (4.14%), State Street Corp (2.80%), Douglas Lane & Associates LLC (1.19%), Congress Asset Management Co. MA (1.10%) and Sei Investments Co. (1.04%). Insiders that own company stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $16.15.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $748.23 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.19 on an earnings per share basis.

How many employees does Core Laboratories have?

The company employs 3,700 workers across the globe.

When was Core Laboratories founded?

Core Laboratories was founded in 1936.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.

This page (NYSE:CLB) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.